Physician profile
Nithya Chalikonda
NPI 1558705251
$5,682.17
in general payments reported to CMS, 2019-2025
7 companies · $392 in 2025
The $392 reported for 2025 was more than what 76% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,378 · 2023: $1,811 · 2024: $1,101 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,193 · Travel and Lodging: $1,008 · Gift: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,193.03 |
| Travel and Lodging | $1,008.09 |
| Gift | $102.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $3,898.39 | 2022-2024 | Invisalign |
| Envista Holdings Corporation | $702.33 | 2024-2025 | Damon, Spark, Mini 2000 |
| Ormco Corporation | $554.87 | 2022-2023 | Spark, Miniendo II |
| Nobel Biocare USA | $359.32 | 2023 | Nobelactive |
| American Orthodontics Corporation | $129.02 | 2024-2025 | Empower-Metal, LP and Ifit Tubes, Radiance |
| World Class Technology Corporation | $22.07 | 2024 | Pitts21, Pitts21 Pro |
| Philips North America LLC | $16.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nithya Chalikonda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.